AHA and the National Independent Laboratory Association flagged for the National Association of Insurance Commissioners deeply concerning actions by UnitedHealthcare to implement a “misleading” new benefit plan design that will limit access to needed laboratory services.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
In a letter to the Uniform Law Commission, the AHA expresses concerns with the draft uniform law provisions on non-compete agreements for health care providers.
The American Hospital Association looks forward to working with CMS on implementing the good faith estimates and advanced explanation of benefits (EOB) required by the No Surprises Act.
In a letter to Representatives Bradley Schneider, David McKinley and Annie Kuster, the AHA expresses support for bipartisan legislation, the Substance Use Disorder Workforce Act,.
In a letter to Senators Margaret Wood Hassan and Susan Collins, the AHA expresses support for bipartisan legislation, the Opioid Workforce Act of 2021 (S. 1438).
AHA express support for bill that would improve maternal health.
AHA Expresses Support for bill that would provide funding and programs to improve maternal health in rural and other areas.
AHA Expresses Support for bill that would provide funding and programs to improve maternal health in rural and other areas.
More than a year has now elapsed since our country began its battle against COVID-19.
The AHA expresses support for legislation H.R. 3203 introduced in the House that would provide certainty to hospitals participating in the 340B Drug Pricing Program during the COVID-19 public health emergency.